South Africa: SAHPRA Moves Closer to a New Medical Device Regulatory Framework

Regulatory Update | September 2026

South Africa's medical-device regulatory landscape is continuing to evolve. The South African Health Products Regulatory Authority (SAHPRA) is advancing work on a more structured regulatory framework with two parallel developments signaling where the market is heading.

In August 2026, SAHPRA called for an independent expert review of its Draft Medical Devices Regulations. Then, on 9 September 2026, the Authority published an addendum extending the deadline for expressions of interest in Phase 2 of its Medical Device Registration Voluntary Feasibility Study to 18 September 2026.

Together, these signal that South Africa's regulatory environment is moving toward further development, testing, and refinement and manufacturers should be paying attention now.

What's Happening?

1. Draft Regulations Under Independent Review

On 24 August 2026, SAHPRA published a Call for Expression of Interest: Independent Expert Review of South Africa's Draft Medical Devices Regulations, which closed on 11 September 2026.

Important distinction: these are still draft regulations. They are not yet a final legal requirement in force but they do indicate the direction South Africa's medical-device regulatory system is heading.

2. Registration Reform Being Tested

SAHPRA is also progressing its Medical Device Registration Voluntary Feasibility Study. Phase 2 was first opened for participation in July 2026; on 9 September 2026, Addendum 1 extended the expression-of-interest deadline to 18 September 2026.

This matters because SAHPRA isn't just revising policy it's actively testing how registration processes will work in practice. For manufacturers, that means future reform could affect not just the rules, but how registration submissions are prepared and processed.

Why This Matters for Medical-Device Companies

South Africa is a key gateway to the broader African healthcare market. As SAHPRA develops its regulatory framework, companies can no longer rely solely on historical registration practices they need to actively monitor change.

This is especially relevant for:

• Manufacturers planning South African market entry

• International manufacturers already supplying the market

• Local representatives and importers

• Teams preparing upcoming registration submissions

• Regulatory and quality teams managing African market access

The takeaway is simple: the framework is evolving and companies should prepare before changes become mandatory.

Draft ≠ Final: A Critical Distinction

Independent expert review is a healthy, necessary step for any regulatory framework but it doesn't mean the draft regulations are already law.

Manufacturers should clearly distinguish between:

Stage What It Means

Current requirements | Rules and procedures currently in force |

Draft regulatory changes | Requirements still under development or review |

Future implementation | Final requirements once formally adopted |

Confusing these stages can lead to premature or delayed regulatory decisions.

Post-Market Requirements Are Evolving Too

Regulatory development isn't limited to registration. On 31 July 2026, SAHPRA published SAHPGL-MD-02 – Guideline for Handling Field Safety Corrective Actions for public comment, with the consultation open until 31 October 2026.

This guideline outlines SAHPRA's expectations for handling Field Safety Corrective Actions (FSCAs) tied to device safety, quality, and performance including for in vitro diagnostics.

The message for manufacturers: market access isn't just about initial registration. Compliance expectations extend into the post-market phase, including how safety issues and corrective actions are managed.

What Should Manufacturers Do Now?

1. Review your current regulatory position

Establish exactly which requirements apply to your products today this is your baseline for assessing future change.

2. Monitor the draft regulations closely

The expert review is a milestone, not the finish line. Track SAHPRA communications for updates on finalization and implementation.

3. Assess registration readiness

If you're planning South African market entry, review what documentation you'll need now early prep avoids scrambling later.

4. Strengthen post-market processes

Ensure your global safety and corrective-action procedures are equipped to meet South African requirements once finalized.

5. Align regulatory strategy across Africa

Don't treat South Africa in isolation assess how these changes intersect with your broader regulatory strategy across African markets sharing similar technical documentation or quality systems.

What This Means for Market Entry

These developments don't require an immediate strategy overhaul based on drafts alone. Instead, they create a window to prepare strategically:

Review → Identify gaps → Monitor → Prepare → Adapt

This lets regulatory teams understand exactly where their documentation and processes stand before new requirements potentially take effect for both new entrants and companies already established in the market.

ARQon Regulatory Insight

South Africa's latest developments reinforce a core principle: regulatory intelligence should begin before a regulation becomes effective not after.

The independent review of the Draft Medical Devices Regulations, paired with the ongoing Registration Feasibility Study, shows SAHPRA is actively shaping both the policy and the practical mechanics of its medical-device system.

For manufacturers, the priority right now isn't predicting exactly what the final framework will look like it's understanding the direction of change and honestly assessing your own readiness for it. This matters most for companies entering South Africa for the first time, where today's market-entry decisions may need to stay flexible as the framework matures.

What to Watch Next

• Progress on the Draft Medical Devices Regulations

• Further SAHPRA communications on device registration

• Outcomes of the Medical Device Registration Voluntary Feasibility Study

• Finalization of the Field Safety Corrective Action guideline

• Any implementation timelines or transitional arrangements

• Additional guidance for manufacturers, importers, and regulatory representatives

Key Takeaway

South Africa is actively advancing its medical-device regulatory framework, with SAHPRA progressing both an expert review of the Draft Medical Devices Regulations and a voluntary feasibility study on device registration.

These are not yet final requirements but they're a clear signal to strengthen regulatory monitoring now.

Companies that prepare for regulatory change before it becomes mandatory are far better positioned to adapt when the rules finally arrive.

How ARQon Can Support You

• Regulatory intelligence and monitoring

• South Africa market-entry strategy

• Medical-device registration planning

• Regulatory gap assessments

• Technical documentation planning

• Post-market regulatory strategy

• Cross-border African market access

• Regulatory representation and local market support

Stay Ahead. Stay Compliant. Stay Informed.

With ARQon Regulatory Intelligence.